BIO-RAD LABORATORIES, INC.

BIO

BIO-RAD LABORATORIES, INC.

BIO

Insider Sentiment (TTM):

Last Purchase:-Last Sale:2026-05-11Shares Purchased (TTM):0Shares Sold (TTM):1,249.87

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:18,973,544Shares Outstanding:26,958,000Institutional Ownership Pct.:70.38%

Earnings Market Reaction:

Filing Date:2026-04-30Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Laboratory Analytical Instruments

A MTD WAT ILMN RVTY BRKR

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	507	530	396	369	521	488	410	407	433	404	458	390
Short Term Investments	1,058	1,011	1,023	1,005	1,139	1,176	1,212	1,209	1,212	1,203	1,301	1,333
Accounts Receivable Net Current	426	461	465	470	425	453	462	446	445	489	457	492
Restricted Investments Current	-	-	-	-	-	0	6	6	6	6	6	6
Inventory Net	771	741	783	799	790	760	804	804	783	781	776	777
Prepaid Expense Current	150	137	152	150	125	123	133	153	143	140	124	123
Other Assets Current	31	28	24	19	36	31	28	32	39	26	25	20
Assets Current	2,942	2,906	2,842	2,811	3,037	3,030	3,056	3,056	3,061	3,048	3,147	3,139
Property Plant And Equipment And Finance Lease Rig…	-	-	-	-	-	-	-	-	-	-	1,539	1,575
Property Plant And Equipment And Finance Lease Rig…	-	-	-	-	-	-	-	-	-	-	1,027	1,061
Property Plant And Equipment And Finance Lease Rig…	528	540	540	550	529	528	545	534	522	529	511	514
Operating Lease Right Of Use Asset	162	170	180	190	153	161	174	181	189	195	200	174
Goodwill	577	580	579	582	415	411	415	412	413	414	407	412
Intangible Assets Net Excluding Goodwill	167	174	388	397	296	294	307	307	314	321	314	329
Long Term Investments	5,312	6,104	5,058	5,577	4,994	4,839	6,003	5,100	8,018	7,698	7,218	7,311
Other Assets Noncurrent	-	103	-	-	-	102	-	-	-	95	-	-
Other Assets	103	-	109	108	104	-	104	98	93	-	98	100
Assets	9,790	10,577	9,696	10,214	9,527	9,364	10,603	9,688	12,610	12,299	11,896	11,978
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	133	129	129	139	138	122	122	127	103	145	112	150
Employee Related Liabilities Current	148	172	183	158	157	124	146	132	146	140	155	155
Notes And Loans Payable Current	401	1	1	1	1	1	1	0	0	1	0	0
Accrued Income Taxes Current	-	37	-	-	-	31	-	-	-	36	-	-
Taxes Payable Current	45	-	45	36	37	-	44	36	34	-	104	74
Operating Lease Liability Current	36	36	37	39	41	42	43	42	40	40	39	37
Other Liabilities Current	154	142	128	175	132	147	142	150	142	162	148	166
Liabilities Current	917	517	522	549	507	468	498	487	466	523	558	582
Long Term Debt Noncurrent	803	1,210	1,201	1,201	1,201	1,200	1,200	1,200	1,199	1,199	1,199	1,198
Deferred Income Tax Liabilities Net	882	1,059	873	961	841	818	1,076	878	1,541	1,476	1,370	1,402
Operating Lease Liability Noncurrent	139	146	156	165	126	131	144	151	160	166	167	147
Other Liabilities Noncurrent	198	199	208	210	173	177	198	194	192	195	186	202
Liabilities	2,939	3,123	2,960	3,085	2,848	2,795	3,116	2,910	3,559	3,558	3,480	3,531
Preferred Units Outstanding	-	-	0	0	0	-	-	-	-	-	-	-
Preferred Stock Value	0	0	0	0	0	0	0	0	-	0	-	-
Additional Paid In Capital	491	476	462	485	476	463	448	475	463	449	439	474
Treasury Stock Value	-	-1,010	-	-	-	-772	-	-	-	-633	-	-
Retained Earnings Accumulated Deficit	7,649	8,176	7,456	7,798	7,480	7,416	8,132	7,479	9,645	9,261	8,911	8,805
Accumulated Other Comprehensive Income Loss Net Of…	-235	-189	-167	-154	-410	-538	-315	-451	-426	-336	-498	-373
Stockholders Equity	6,851	7,454	6,737	7,129	6,679	6,569	7,488	6,779	9,051	8,741	8,416	8,447
Liabilities And Stockholders Equity	9,790	10,577	9,696	10,214	9,527	9,364	10,603	9,688	12,610	12,299	11,896	11,978
Common Stock	-	0	-	-	-	0	-	-	-	0	-	-
Common Class A	-	22	-	-	-	0	-	-	-	0	-	-
Common Class B	-	5	-	-	-	0	-	-	-	0	-	-
Allowance For Doubtful Accounts Receivable	-	6	-	-	-	9	-	-	-	15	-	-
Treasury Stock Common Shares	-	3	-	-	-	2	-	-	-	2	-	-
Treasury Stock Common	3	-	0	870	-867	-	-54	-94	-630	-	22	-200
Allowance For Doubtful Accounts Receivable Current	5	-	6	7	8	-	12	14	15	-	15	16
Preferred Stock Shares Authorized	8	8	-	-	-	8	8	8	-	8	-	-
Preferred Stock Shares Outstanding	0	0	-	-	-	0	-	-	-	0	-	-
Preferred Stock Shares Issued	0	-	-	-	-	-	0	0	-	-	-	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	-	0	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	2.72%	0.83%	8.65%	-	-	-	-	-	-	-	-	-
2025	-6.93%	-1.53%	2.48%	25.57%	17.41%	28.13%	-0.87%	-5.62%	-1.86%	5.18%	9.13%	0.00%
2024	6.93%	1.81%	19.07%	-6.25%	-1.76%	3.11%	-7.06%	-8.58%	-4.41%	-5.76%	-18.60%	-14.73%
2023	-1.62%	-5.05%	7.51%	-4.56%	-11.74%	-22.30%	10.60%	13.09%	17.69%	0.95%	-4.68%	-17.82%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 50+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Liquidity Ratios
Current Ratio	3.21	5.62	5.44	5.12	5.99	6.48	6.14	6.28	6.57	5.83	5.64	5.39
Quick Ratio	2.20	3.92	3.65	3.39	4.19	4.59	4.25	4.31	4.58	4.07	4.03	3.85
Working Capital	2.03B	2.39B	2.32B	2.26B	2.53B	2.56B	2.56B	2.57B	2.59B	2.53B	2.59B	2.56B
Leverage & Debt
Debt to Equity	0.43	0.42	0.44	0.43	0.43	0.43	0.42	0.43	0.39	0.41	0.41	0.42
Interest Coverage TTM	1.17	0.96	4.57	4.57	5.10	5.50	6.24	6.74	6.49	6.84	7.41	7.60
Debt Ratio	0.30	0.30	0.31	0.30	0.30	0.30	0.29	0.30	0.28	0.29	0.29	0.29
Efficiency & Turnover
Asset Turnover TTM	0.20	0.19	0.19	0.19	0.17	0.18	0.17	0.17	0.15	0.15	0.17	0.17
Days Sales Outstanding TTM	81.87	88.17	89.48	88.55	84.70	90.48	88.35	90.90	89.45	90.21	81.59	84.31
Receivables Turnover TTM	4.46	4.14	4.08	4.12	4.31	4.03	4.13	4.02	4.08	4.05	4.47	4.33
Per Share Metrics
Diluted EPS TTM	6.26	27.85	-25.10	11.72	-77.41	-65.36	-27.82	-46.68	-11.30	-21.82	-5.45	-14.59
Free Cash Flow Per Share TTM	13.25	13.74	12.51	13.63	12.72	10.26	8.84	6.24	6.50	7.47	7.71	5.25
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	70.82%	70.89%	70.72%	71.51%	72.53%	72.61%	73.89%	73.51%	72.26%	71.70%	73.25%	73.31%
Operating Profit Margin TTM	3.04%	2.50%	11.88%	11.86%	13.24%	14.17%	16.11%	17.67%	16.66%	16.97%	18.15%	17.90%
Net Profit Margin TTM	8.90%	40.21%	-35.76%	16.92%	-115.50%	-97.11%	-41.00%	-70.46%	-16.75%	-32.02%	-8.00%	-21.01%
Growth Metrics
Net Revenue Growth (1Y)	1.23%	-0.47%	-0.47%	0.28%	-2.62%	-4.58%	-4.58%	-7.72%	-6.09%	-3.95%	-3.95%	-4.65%
Net Income Growth (1Y)	-107.80%	-141.20%	-13.20%	-124.08%	571.33%	189.38%	388.81%	209.46%	68.58%	-82.43%	-97.35%	-77.80%
EPS Growth (1Y)	-108.08%	-142.64%	-9.89%	-125.11%	585.19%	199.58%	408.98%	219.92%	74.95%	-82.09%	-97.30%	-77.47%
Valuation Metrics
P/E TTM	44.52	10.87	-11.17	20.58	-3.14	-5.03	-12.01	-5.85	-30.60	-14.80	-65.48	-25.98
P/B TTM	1.10	1.11	1.12	0.92	1.02	1.41	1.25	1.14	1.09	1.08	1.24	1.32
P/S TTM	3.96	4.37	3.99	3.48	3.63	4.88	4.92	4.12	5.13	4.74	5.24	5.46
Market Cap	7.51B	8.26B	7.55B	6.57B	6.81B	9.27B	9.35B	7.75B	9.86B	9.43B	10.43B	11.13B
Enterprise Value	7.81B	8.94B	8.35B	7.40B	7.48B	9.98B	10.14B	8.55B	10.63B	10.23B	11.17B	11.94B
Calculated Values
Free Cash Flow TTM	357.20M	374.60M	336.80M	371.00M	355.50M	289.60M	247.04M	177.28M	185.41M	218.20M	224.32M	154.14M
Net Debt	293.90M	680.20M	803.20M	831.80M	677.60M	710.60M	787.86M	792.02M	766.08M	794.70M	740.40M	807.90M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-05-11Sale

Owner: Engelhardt, Eva Anette

Title: EVP, President, CDG

Shares: 550

Price/Share: $246.54

Value: $135,597.00

Shares Owned: 346

Relationship: Officer

Ownership: Direct

2025-11-06Sale

Owner: Barry, James

Title: EVP, President, LSG

Shares: 700

Price/Share: $306.18

Value: $214,286.20

Shares Owned: 510

Relationship: Officer

Ownership: Direct

2025-03-14Sale

Owner: Crowley, Michael

Title: EVP, GBL Commercial Operations

Shares: 3,000

Price/Share: $247.06

Value: $741,180.00

Shares Owned: 8,171

Relationship: Officer

Ownership: Direct

2024-09-06Sale

Owner: Last, Andrew J.

Title: EVP, Chief Operating Officer

Shares: 3,000

Price/Share: $329.94

Value: $989,820.00

Shares Owned: 7,559

Relationship: Officer

Ownership: Direct

2024-09-04Sale

Owner: Barry, James

Title: EVP, President, LSG

Shares: 623

Price/Share: $330.49

Value: $205,895.27

Shares Owned: 147

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-05-11	Engelhardt, Eva Anette	Officer	EVP, President, CDG	Direct	Sale	550	246.54	$135,597.00	346	4
2025-11-06	Barry, James	Officer	EVP, President, LSG	Direct	Sale	700	306.18	$214,286.20	510	4
2025-03-14	Crowley, Michael	Officer	EVP, GBL Commercial Operations	Direct	Sale	3,000	247.06	$741,180.00	8,171	4
2024-09-06	Last, Andrew J.	Officer	EVP, Chief Operating Officer	Direct	Sale	3,000	329.94	$989,820.00	7,559	4
2024-09-04	Barry, James	Officer	EVP, President, LSG	Direct	Sale	623	330.49	$205,895.27	147	4
2024-06-13	Crowley, Michael	Officer	EVP, GBL Commercial Operations	Direct	Sale	369	281.91	$104,024.79	6,573	4
2024-02-28	Ernst, Timothy S	Officer	EVP, General Counsel & Sec	Direct	Sale	2,500	330.55	$826,375.00	3,397	4
2024-02-27	Crowley, Michael	Officer	EVP, GBL Commercial Operations	Direct	Sale	3,000	336.00	$1,008,000.00	6,942	4
2023-12-12	Wright, Dara	Officer	EVP, President, CDG	Direct	Sale	1,200	299.16	$358,992.00	1,499	4
2023-11-28	Crowley, Michael	Officer	EVP, GBL Commercial Operations	Direct	Sale	642	305.10	$195,874.20	6,942	4
2023-08-30	Ernst, Timothy S	Officer	EVP, General Counsel & Sec	Direct	Sale	2,350	395.45	$929,307.50	2,416	4
2023-08-23	Ernst, Timothy S	Officer	EVP, General Counsel & Sec	Direct	Sale	300	384.69	$115,407.00	2,416	4
2023-06-15	Crowley, Michael	Officer	EVP, GBL Commercial Operations	Direct	Sale	500	379.39	$189,695.00	6,040	4
2023-06-06	Ramalingam, Ajit	Officer	SVP, Chief Accounting Officer	Direct	Sale	198	368.38	$73,068.17	0	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

70.38%

Inst. Shares: 18,973,544

Shares Outstanding: 26,958,000

2025-12-31

68.01%

Inst. Shares: 18,540,490

Shares Outstanding: 27,263,000

2025-09-30

68.58%

Inst. Shares: 18,464,692

Shares Outstanding: 26,923,000

2025-06-30

66.52%

Inst. Shares: 18,110,601

Shares Outstanding: 27,226,000

2025-03-31

63.31%

Inst. Shares: 17,688,956

Shares Outstanding: 27,941,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	18,973,544	26,958,000	70.38%
2025-12-31	18,540,490	27,263,000	68.01%
2025-09-30	18,464,692	26,923,000	68.58%
2025-06-30	18,110,601	27,226,000	66.52%
2025-03-31	17,688,956	27,941,000	63.31%
2024-12-31	18,265,002	28,214,000	64.74%
2024-09-30	16,669,301	27,949,000	59.64%
2024-06-30	18,243,318	28,395,000	64.25%
2024-03-31	17,137,106	28,518,000	60.09%
2023-12-31	17,638,982	29,209,000	60.39%
2023-09-30	17,669,783	29,102,000	60.72%
2023-06-30	17,440,731	29,355,000	59.41%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

BIO-RAD LABORATORIES, INC. (BIO) — SEC Financial Statements & Analysis

BIO-RAD LABORATORIES, INC. (BIO) is a laboratory analytical instruments company, incorporated in DE. BIO-RAD LABORATORIES, INC. trades on BIO-B: NYSE as: BIO: NYSE. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), BIO-RAD LABORATORIES, INC. reported a 1.23% year-over-year revenue growth, a Gross Profit Margin of 70.82% (TTM), a Debt-to-Equity ratio of 0.43x, a Price-to-Sales (P/S) ratio of 3.96x (TTM), a Price-to-Book (P/B) ratio of 1.1 (TTM), at a market cap of $7.51B. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: 1.23%
Gross Profit Margin TTM: 70.82%
Debt To Equity: 0.43x
P/S TTM: 3.96x
P/B TTM: 1.1
Market Cap: $7.51B

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is BIO-RAD LABORATORIES, INC. in?

BIO-RAD LABORATORIES, INC. (BIO) operates in the Laboratory Analytical Instruments industry.

What is BIO's market cap?

BIO-RAD LABORATORIES, INC. (BIO) has a market capitalization of $7.51B as of 2026-03-31.

What is BIO's P/E ratio?

BIO-RAD LABORATORIES, INC. (BIO)'s trailing twelve month P/E ratio is 44.52x as of 2026-03-31.

What exchange does BIO trade on?

BIO-RAD LABORATORIES, INC. (BIO) trades on the BIO-B: NYSE.

Where is BIO-RAD LABORATORIES, INC. incorporated?

BIO-RAD LABORATORIES, INC. is incorporated in DE.

BIO-RAD LABORATORIES, INC. (BIO) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.